Abstract
Pediatric 18F-FDG PET/CT, and more recently PET/MR imaging, have undergone tremendous evolution in the last decade. While general imaging guidelines are similar in adults and children, special care is needed in the latter group to ensure optimal examination quality while minimizing potential adverse effects, including dose optimization for both radiopharmaceutical activity and CT parameters, use of sedation when appropriate, and adequate patient preparation. Clinical indications are very different from those in adults, as cardiovascular disease is infrequent in children, and mostly related to congenital heart disease, infection evaluation, as well as viability studies in Kawasaki disease or anomalous coronaries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Edwards KW. Preparation and logistic considerations in performing PET and PET/computed tomography in pediatric patients. PET Clin. 2020;15(3):285–92.
Fahey FH, Goodkind A, MacDougall RD, Oberg L, Ziniel SI, Cappock R, et al. Operational and dosimetric aspects of pediatric PET/CT. J Nucl Med. 2017;58(9):1360–6.
Paiva FG, do Carmo Santana P, Mourao AP. Dosimetric study of pediatric PET/CT scan using different phantoms. Radiat Phys Chem. 2020;173:108887.
Parisi MT, Bermo MS, Alessio AM, Sharp SE, Gelfand MJ, Shulkin BL. Optimization of pediatric PET/CT. Semin Nucl Med. 2017;47:258–74.
Fahey FH, Goodkind AB, Plyku D, Khamwan K, O’Reilly SE, Cao X, et al. Dose estimation in pediatric nuclear medicine. Semin Nucl Med. 2017;47:118–25.
Treves ST, Gelfand MJ, Fahey FH, Parisi MT. 2016 update of the north American consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med. 2016;57(12):15N–8N.
Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, et al. SNMMI procedure standard/EANM practice guideline on pediatric 18F-FDG PET/CT for oncology 1.0. J Nucl Med. 2021;62(1):99–110.
Alessio AM, Kinahan PE, Manchanda V, Ghioni V, Aldape L, Parisi MT. Weight-based, low-dose pediatric whole-body PET/CT protocols. J Nucl Med. 2009;50(10):1570–8.
Turpin S, Abikhzer G, Lambert R. Simplified weight-based, low dose pediatric F18-FDG PET/CT protocols: dosimetry. J Nucl Med. 2011;52(supplement 1):1389.
McQuattie S. Pediatric PET/CT imaging: tips and techniques. J Nucl Med Technol. 2008;36(4):171–8.
Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med. 1992;33(7):1255–62.
Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017;24(1):86–99.
Schultz ML, Niescierenko M. Guidance for implementing pediatric procedural sedation in resource-limited settings. Clin Pediatr Emerg Med. 2019;20(2):116–22.
Mandell GA, Majd M, Shalaby-Rana E, Gordon I. Society of nuclear medicine procedure guideline for pediatric sedation in nuclear medicine. J Nucl Med. 2003;44:173–4.
Rosen D, Gamble J, Matava C. Canadian pediatric anesthesia society statement on clear fluid fasting for elective pediatric anesthesia. Can J Anesth. 2019;66(8):991–2.
Toney M, Pattishall S, Garber M. The time is now: standardized sedation training for pediatric hospitalists. Pediatrics. 2020;145(5):e20200446.
Sivaramakrishnan G, Sridharan K. Nitrous oxide and midazolam sedation: a systematic review and meta-analysis. Anesth Prog. 2017;64(2):59–65.
Eberson CP, Hsu RY, Borenstein TR. Procedural sedation in the emergency department. J Am Acad Orthop Surg. 2015;23(4):233–42.
Franco A. Current perspectives of pediatric PET/MRI. Clin Pediatr. 2019;2:1016.
Mannheim JG, Schmid AM, Schwenck J, Katiyar P, Herfert K, Pichler BJ, et al. PET/MRI hybrid systems. Semin Nucl Med. 2018;48:332–47.
Bezrukov I, Schmidt H, Gatidis S, Mantlik F, Schäfer JF, Schwenzer N, et al. Quantitative evaluation of segmentation-and atlas-based attenuation correction for PET/MR on pediatric patients. J Nucl Med. 2015;56(7):1067–74.
Boxt LM. Magnetic resonance and computed tomographic evaluation of congenital heart disease. J Magn Reson Imaging. 2004;19(6):827–47.
Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. 2005;25(6):1535–46.
Purz S, Sabri O, Viehweger A, Barthel H, Kluge R, Sorge I, et al. Potential pediatric applications of PET/MR. J Nucl Med. 2014;55(Supplement 2):32S–9S.
Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, et al. PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol. 2013;43(7):860–75.
Takalkar A, Chen W, Desjardins B, Alavi A, Torigian DA. Cardiovascular imaging with PET, CT, and MR imaging. PET Clin. 2008;3(3):411–34.
Rischpler C, Nekolla SG, Dregely I, Schwaiger M. Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med. 2013;54(3):402–15.
Rife E, Gedalia A. Kawasaki disease: an update. Curr Rheumatol Rep. 2020;22(10):75.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc. 2016;5(9):e003289.
Hernandez-Pampaloni M, Allada V, Fishbein MC, Schelbert HR. Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography, coronary angiography, and histopathology. J Am Coll Cardiol. 2003;41(4):618–26.
Frommelt PC, Frommelt MA. Congenital coronary artery anomalies. Pediatr Clin North Am. 2004;51(5):1273–88.
Gittenberger-de Groot AC, Koenraadt WMC, Bartelings MM, Bökenkamp R, DeRuiter MC, Hazekamp MG, et al. Coding of coronary arterial origin and branching in congenital heart disease: the modified Leiden convention. J Thorac Cardiovasc Surg. 2018;156(6):2260–9.
Sithamparanathan S, Padley SPG, Rubens MB, Gatzoulis MA, Ho SY, Nicol ED. Great vessel and coronary artery anatomy in transposition and other coronary anomalies: a universal descriptive and alphanumerical sequential classification. JACC Cardiovasc Imaging. 2013;6(5):624–30.
Click RL, Holmes DR, Vlietstra RE, Kosinski AS, Kronmal RA. Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival—a report from the Coronary Artery Surgery Study. J Am Coll Cardiol. 1989;13(3):531–7.
Davis JA, Cecchin F, Jones TK, Portman MA. Major coronary artery anomalies in a pediatric population: incidence and clinical importance. J Am Coll Cardiol. 2001;37(2):593–7.
Dodge-Khatami A, Mavroudis C, Backer CL. Anomalous origin of the left coronary artery from the pulmonary artery: collective review of surgical therapy. Ann Thorac Surg. 2002;74(3):946–55.
Backer CL, Stout MJ, Zales VR, Muster AJ, Weigel TJ, Idriss FS, et al. Anomalous origin of the left coronary artery. A twenty-year review of surgical management. J Thorac Cardiovasc Surg. 1992;103(6):1049–57; discussion 1057-1058.
Azour L, Jacobi AH, Alpert JB, Uppu S, Latson L, Mason D, et al. Congenital coronary artery anomalies and implications. J Thorac Imaging. 2018;33(5):W30–8.
Walsh R, Nielsen JC, Ko HH, Sanz J, Srivastava S, Parness IA, et al. Imaging of congenital coronary artery anomalies. Pediatr Radiol. 2011;41(12):1526–35.
Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.
McElhinney DB, Reddy VM, Silverman NH, Hanley FL. Modified Damus-Kaye-Stansel procedure for single ventricle, subaortic stenosis, and arch obstruction in neonates and infants: midterm results and techniques for avoiding circulatory arrest. J Thorac Cardiovasc Surg. 1997;114(5):718–25; discussion 725-726.
Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58.
Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, et al. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging. 2020;21(12):1320–30.
Yabrodi M, Hermann JL, Brown JW, Rodefeld MD, Turrentine MW, Mastropietro CW. Minimization of surgical site infections in patients with delayed sternal closure after pediatric cardiac surgery. World J Pediatr Congenit Heart Surg. 2019;10(4):400–6.
Jha P, Woodward CS, Gardner H, Pietz C, Husain SA. A quality improvement initiative to reduce surgical site infections in patients undergoing delayed sternal closure after pediatric cardiac surgery. Pediatr Cardiol. 2020;41(7):1402–7.
Hariri H, Tan S, Martineau P, Lamarche Y, Carrier M, Finnerty V, et al. Utility of FDG-PET/CT for the detection and characterization of sternal wound infection following sternotomy. Nucl Med Mol Imaging. 2019;53(4):253–62.
Pelletier-Galarneau M, Abikhzer G, Harel F, Dilsizian V. Detection of native and prosthetic valve endocarditis: incremental attributes of functional FDG PET/CT over morphologic imaging. Curr Cardiol Rep. 2020;22(9):93.
Pizzi MN, Dos-Subirà L, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Pijuan Domènech A, et al. 18F-FDG-PET/CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material. Int J Cardiol. 2017;248:396–402.
Partington SL, Valente AM, Landzberg M, Grant F, Di Carli MF, Dorbala S. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease. J Nucl Cardiol. 2016;23(1):45–63.
Zhang Y, Williams H, Pucar D. FDG-PET identification of infected pulmonary artery conduit following tetralogy of Fallot (TOF) repair. Nucl Med Mol Imaging. 2017;51(1):86–7.
Meyer Z, Fischer M, Koerfer J, Laser KT, Kececioglu D, Burchert W, et al. The role of FDG-PET-CT in pediatric cardiac patients and patients with congenital heart defects. Int J Cardiol. 2016;220:656–60.
Kouijzer IJE, Mulders-Manders CM, Bleeker-Rovers CP, Oyen WJG. Fever of unknown origin: the value of FDG-PET/CT. Semin Nucl Med. 2018;48(2):100–7.
Pijl JP, Kwee TC, Legger GE, Peters HJH, Armbrust W, Schölvinck EH, et al. Role of FDG-PET/CT in children with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2020;47(6):1596–604.
Blokhuis GJ, Bleeker-Rovers CP, Diender MG, Oyen WJG, Draaisma JMT, de Geus-Oei L-F. Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression. Eur J Nucl Med Mol Imaging. 2014;41(10):1916–23.
Jeewa A, Imamura M, Canter C, Niebler RA, VanderPluym C, Rosenthal DN, et al. Long-term outcomes after transplantation after support with a pulsatile pediatric ventricular assist device. J Heart Lung Transplant. 2019;38(4):449–55.
Absi M, Bocchini C, Price JF, Adachi I. F-fluorodeoxyglucose-positive emission tomography/CT imaging for left ventricular assist device-associated infections in children. Cardiol Young. 2018;28(10):1157–9.
Burki S, Adachi I. Pediatric ventricular assist devices: current challenges and future prospects. Vasc Health Risk Manag. 2017;13:177–85.
Dell’Aquila AM, Mastrobuoni S, Alles S, Wenning C, Henryk W, Schneider SRB, et al. Contributory role of fluorine 18-Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis and clinical Management of Infections in patients supported with a continuous-flow left ventricular assist device. Ann Thorac Surg. 2016;101(1):87–94. discussion 94
Mahmood M, Kendi AT, Ajmal S, Farid S, O’Horo JC, Chareonthaitawee P, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019;26(3):922–35.
Turpin S, Lambert R, Poirier N. An unusual looking pacemaker infection imaged with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2010;37(7):1438.
Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH, et al. Management of acute and recurrent pericarditis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(1):76–92.
Kim M-S, Kim E-K, Choi JY, Oh JK, Chang S-A. Clinical utility of [18F]FDG-PET/CT in pericardial disease. Curr Cardiol Rep. 2019;21(9):107.
Martineau P, Dilsizian V, Pelletier-Galarneau M. Incremental value of FDG-PET in the evaluation of cardiac masses. Curr Cardiol Rep. 2021;23(7):78.
Bligh MP, Borgaonkar JN, Burrell SC, MacDonald DA, Manos D. Spectrum of CT findings in thoracic extranodal non-Hodgkin lymphoma. Radiographics. 2017;37(2):439–61.
Gerardin C, Mageau A, Benali K, Jouan F, Ducrocq G, Alexandra J-F, et al. Increased FDG-PET/CT pericardial uptake identifies acute pericarditis patients at high risk for relapse. Int J Cardiol. 2018;271:192–4.
Dong A, Dong H, Wang Y, Cheng C, Zuo C, Lu J. (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study. Clin Nucl Med. 2013;38(4):e160–5.
Pelletier-Galarneau M, Martineau P, Zuckier LS, Pham X, Lambert R, Turpin S. 18F-FDG-PET/CT imaging of thoracic and extrathoracic tuberculosis in children. Semin Nucl Med. 2017;47:304–18.
Chang SA, Oh JK. Constrictive pericarditis: a medical or surgical disease? J Cardiovasc Imaging. 2019;27(3):178–86.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
April, G., Turpin, S., Lambert, R., Miró, J. (2022). Pediatrics Cardiovascular FDG-PET Imaging. In: Pelletier-Galarneau, M., Martineau, P. (eds) FDG-PET/CT and PET/MR in Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-09807-9_21
Download citation
DOI: https://doi.org/10.1007/978-3-031-09807-9_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09806-2
Online ISBN: 978-3-031-09807-9
eBook Packages: MedicineMedicine (R0)